-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
March 01, 2016 - Population – infants (29 days to 1 year) (specify age range): No.
q. … function and current libido, in addition to factors such as
duration of second-stage labor, size of infant
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0083episiotomy.pdf
March 01, 2016 - Population – infants (29 days to 1 year) (specify age range): No.
q. … function and current libido, in addition to factors such as
duration of second-stage labor, size of infant
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2021qdr-appendixes.pdf
December 01, 2021 - National Tuberculosis Surveillance System (NTSS)
• National Vital Statistics System—Linked Birth and Infant … who completed a curative
treatment within 1 year of initiation of treatment
course of NTBSS 2017
Infants
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_executive.pdf
March 01, 2014 - In 2008,
manufactures voluntarily removed over-the-counter infant
(<2 years of age) cough and cold … Special Features:
An Important FDA Reminder for Parents: Do Not Give Infants
Cough and Cold Products
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-241-bmi-communication-full-report.pdf
February 01, 2020 - This includes reliable scales for infants
and children, recumbent infant length boards, and wall-mounted … Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp3.pdf
March 01, 2009 - Death outcomes include all-cause or total mortality, infant mortality, and fetal neural tube defects … Eye outcomes include cataracts, infant eye outcomes, and age-related macular disease
8. … Pregnancy or birth outcomes include preeclampsia, preterm delivery or prematurity, infant growth retardation
-
hcup-us.ahrq.gov/reports/methods/2006_6a.pdf
January 01, 2006 - distribution, race/ethnic composition, and poverty
Geographic Entity:
State
Diseases and Health:
Infant … mortality rate, low birth weight infants, deaths per 100,000 population for various
diseases, utilization … more), county
Diseases and Health:
Births, deaths (including cause), fetal deaths, linked birth/infant
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-201-fullreport.pdf
March 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q. … Breathing easier: Addressing the challenges of aerosolizing medications
to infants and preschoolers.
-
effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
January 01, 2012 - The estimated mortality rate in
infants with SBS is 30%. … care per child with SBS
over a 5-year period was $1.6 million.
39
The estimated mortality rate in infants
-
effectivehealthcare.ahrq.gov/health-topics/breastfeeding
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_surveillance.pdf
January 30, 2013 - difference between the SQ terbutaline
pump and oral tocolytics in
requirement for ventilator among
infants … difference between the SQ terbutaline pump
and oral tocolytics in requirement for ventilator among
infants
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_surveillance.pdf
January 30, 2013 - difference between the SQ terbutaline
pump and oral tocolytics in
requirement for ventilator among
infants … difference between the SQ terbutaline pump
and oral tocolytics in requirement for ventilator among
infants
-
www.ahrq.gov/hai/cusp/clabsi-neonatal/nclabsi4.html
January 01, 2013 - Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention
Results
Previous Page Next Page
Table of Contents
Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention
Executive Summary
Introduction & Objectives
Methods
Data Collection and …
-
www.ahrq.gov/hai/cusp/clabsi-neonatal/nclabsi3.html
January 01, 2013 - Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention
Data Collection and Analysis
Previous Page Next Page
Table of Contents
Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention
Executive Summary
Introduction & Objectives
Methods
…
-
www.ahrq.gov/hai/cusp/clabsi-neonatal/nclabsi5.html
January 01, 2013 - Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention
Rates
Previous Page Next Page
Table of Contents
Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention
Executive Summary
Introduction & Objectives
Methods
Data Collection and An…
-
www.ahrq.gov/hai/cusp/clabsi-neonatal/nclabsi6.html
January 01, 2013 - Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention
Impact
Previous Page Next Page
Table of Contents
Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention
Executive Summary
Introduction & Objectives
Methods
Data Collection and A…
-
www.ahrq.gov/hai/cusp/clabsi-neonatal/nclabsi8.html
January 01, 2013 - Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention
Next Steps
Previous Page
Table of Contents
Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention
Executive Summary
Introduction & Objectives
Methods
Data Collection and Analy…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/LgA7neX9UurPQRh3pJaYXY
April 25, 2017 - IMPORTANCE Preeclampsia is a complex disease of pregnancy with sometimes serious
effects on maternal and infant … MAIN OUTCOMES AND MEASURES Maternal and infant health outcomes, including eclampsia,
stroke, stillbirth … preeclampsia is
diagnosed, evidence-based interventions may reduce the risk or
severity of maternal and infant … from ran-
domized clinical trials (RCTs) and observational studies that re-
ported on maternal and infant
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ghbfx9e3A6jQEqVW26y8Jv
March 09, 2021 - Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the USPSTF
Screening for Lung Cancer With Low-Dose Computed Tomography
Updated Evidence Report and Systematic Review
for the US Preventive Services Task Force
Daniel E. Jonas, MD, MPH; Daniel S. Reuland, MD,…
-
effectivehealthcare.ahrq.gov/health-topics/bronchial-disorders